Abstract
Galectin-2 is a prototype member of the galactoside-binding galectin family. It is predominately expressed in the gastrointestinal tract but is also detected in several other tissues such as the placenta and in the cardiovascular system. Galectin-2 expression and secretion by epithelial cells has been reported to contribute to the strength of the mucus layer, protect the integrity of epithelia. A number of studies have also suggested the involvement of galectin-2 in tissue inflammation, immune response and cell apoptosis. Alteration of galectin-2 expression occurs in inflammatory bowel disease, coronary artery diseases, rheumatoid arthritis, cancer, and pregnancy disorders and has been shown to be involved in disease pathogenesis. This review discusses our current understanding of the role and actions of galectin-2 in regulation of these pathophysiological conditions.
Funder
Nigeria Tertiary Education Trust Fund Oversea Scholarship
Cancer Research UK
Northwest Cancer Research Fund
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference68 articles.
1. Galectins at a glance;Johannes;J. Cell Sci.,2018
2. A β D galactoside binding protein from electric organ tissue of Electrophorus electricus;Teichberg;Proc. Natl. Acad. Sci. USA,1975
3. The galectin lattice at a glance;Nabi;J. Cell Sci.,2015
4. Hara, A., Niwa, M., Noguchi, K., Kanayama, T., Niwa, A., Matsuo, M., Hatano, Y., and Tomita, H. (2020). Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases. Biomolecules, 10.
5. Isolation and expression of a gene encoding L-14-II, a new human soluble lactose-binding lectin;Gitt;J. Biol. Chem.,1992
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献